Sign In
Buy PEN
$316.20
-1.00 (-0.315%)
At Close: Jun 22, 2026
GMED vs. PEN: Which Stock Should Value Investors Buy Now?
12:41pm, Monday, 22'nd Jun 2026
Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Penumbra (PEN). But which of these two stocks presents investors with the better
Penumbra Receives CE Nod for THUNDERBOLT: Stock to Gain?
01:51pm, Thursday, 18'th Jun 2026
PEN gains CE Mark in Europe for THUNDERBOLT, expanding stroke treatment access and advancing its global stroke care strategy.
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT
09:00am, Monday, 15'th Jun 2026
The THUNDERBOLT TM Computer Assisted Vacuum Thrombectomy (CAVT TM ) technology introduces modulated aspiration for acute ischemic stroke for the first time, enabling more rapid, complete clot removal
Penumbra's THUNDERBOLT Receives FDA Clearance - Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke
04:05pm, Thursday, 11'th Jun 2026
THUNDERBOLT is the first CAVT platform to deliver modulated aspiration for acute ischemic stroke — enabling faster, more complete clot removal ALAMEDA, Calif., June 11, 2026 /PRNewswire/ -- Penumbra
GMED or PEN: Which Is the Better Value Stock Right Now?
12:40pm, Friday, 05'th Jun 2026
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and Penumbra (PEN). But which of these two companies is the best option for th
Why Is Penumbra (PEN) Down 1.2% Since Last Earnings Report?
12:36pm, Friday, 05'th Jun 2026
Penumbra (PEN) reported earnings 30 days ago. What's next for the stock?
Artisan Small Cap Fund Q1 2026 Portfolio Activity
09:15am, Thursday, 07'th May 2026
During the quarter, we initiated new Garden positions in Onto Innovation, Baldwin Group and Freshpet. In addition to Compass, we added to our positions in Ollie's Bargain Outlet and Flowserve during t
Penumbra (PEN) Misses Q1 Earnings Estimates
06:25pm, Wednesday, 06'th May 2026
Penumbra (PEN) came out with quarterly earnings of $0.82 per share, missing the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.83 per share a year ago.
Penumbra, Inc. Reports First Quarter 2026 Financial Results
04:05pm, Wednesday, 06'th May 2026
ALAMEDA, Calif., May 6, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the first quarter ended March 31, 2026.
ALC vs. PEN: Which Stock Should Value Investors Buy Now?
12:41pm, Tuesday, 05'th May 2026
Investors with an interest in Medical - Instruments stocks have likely encountered both Alcon (ALC) and Penumbra (PEN). But which of these two stocks presents investors with the better value opportuni
3 Reasons Why Penumbra (PEN) Is a Great Growth Stock
01:45pm, Monday, 27'th Apr 2026
Penumbra (PEN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why Penumbra (PEN) is a Strong Growth Stock
10:45am, Wednesday, 15'th Apr 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ALAMEDA, Calif., April 13, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) announced 90-day results of the landmark STORM-PE randomized controlled trial (RCT), which found that patients with acute in
3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN)
01:45pm, Friday, 10'th Apr 2026
Penumbra (PEN) could produce exceptional returns because of its solid growth attributes.
Are OMEX, PEN, SNCY, CWAN Obtaining Fair Deals for their Shareholders?
01:41pm, Friday, 10'th Apr 2026
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
